快猫短视频

Skip to main content

References: Thymus Cancer

On this page

Cameron RB, Loehrer PJ, Thomas CR. Neoplasms of the mediastinum. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:871-881.

Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006 Jun;81(6):2328-2334.

Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S260-S2605.

Glisson BS, Movsas B, Scott W. Small-cell lung cancer, mesothelioma, and thymoma. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, eds. Cancer Management: A Multidisciplinary Approach. 11th ed. Lawrence, KS: CMPMedica; 2008:163-168.

Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;76(3):878-884; discussion 884-885.

Lucchi M, Ambrogi MC, Duranti L, et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg. 2005;79:1840-1844.

National Cancer Institute. Physician Data Query (PDQ). Thymoma and Thymic Carcinoma: Treatment. 9/17/2012. Accessed at www.cancer.gov/cancertopics/pdq/treatment/thymoma/healthprofessional on January 3, 2014.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Thymomas and Thymic carcinomas. V.1.2014. Accessed at www.nccn.org on January 3, 2014.

Rajan A, Carter CA, Berman A, et al. Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. Lancet Oncol. 2014 Feb;15(2):191-200. Epub 2014 Jan 15.

Riedel RF, Burfeind WR. Thymoma: benign appearance, malignant potential. Oncologist. 2006;11:887-894.

Ronckers CM, McCarron P, Engels EA, Ron E. New Malignancies Following Cancer of the Thyroid and Other Endocrine Glands. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (eds). New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute. NIH Publ. No. 05-5302. Bethesda, MD, 2006. Accessed on 4/18/2014 at http://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdf.

Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2020;70(4). doi:10.3322/caac.21591. Accessed at https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21591 on June 9, 2020.

Sovak MA, Aisner SC, Aisner J. Tumors of the pleura and mediastinum. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1367-1398.

Suster S, Moran CA. Thymoma classification. Current status and future trends. Am J Clin Pathol. 2006;125:542-554.

Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999;17:2280-2289.

Vaena DA, Henley J, Loehrer PJ. Thymoma and thymic carcinoma. In: Pass HI, Carbone DP, Johnson DH, Minna JD, Turrisi AT, eds. Lung Cancer: Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:867-880.

Young JL, Ward KC, Ries LAG. Cancers of rare sites. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.